{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:19:16Z","timestamp":1793035156949,"version":"4.5.0"},"reference-count":183,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psoriasis is a systemic autoimmune disease with roles in the innate and adaptive immune systems. Histological features include aberrant vascularization with dilated, tortuous, thin-walled capillaries and a mixed inflammatory infiltrate with mononuclear cells and neutrophils. There is increasing evidence that oxidative stress (hypoxia) plays an important role in vascular and inflammatory processes in the pathogenesis of psoriasis. In addition, it appears that systemic inflammation and oxidative stress could be a mechanistic link between psoriasis and concomitant cardiometabolic disorders. To present a unifying overview of the current literature on the general concept on the interrelationship between oxidative stress, vascular alternations and inflammation within the pathogenesis of psoriasis. More particularly, we aimed to gain insight into the pathomechanisms related to cardiovascular comorbidities \u2013 an important and distressing component of psoriatic disease. Standardized literature searches in PubMed and Embase were carried out with a focus on oxidative stress, inflammation and vascularization in psoriasis. In this article, the current knowledge on the role of oxidative stress in the inflammatory and vascular aspects of the pathogenesis of psoriasis are stated. Moreover, contemporary awareness of the pathomechanisms related to cardiovascular diseases are pointed out. The review presents arguments to underline the importance of hypoxia and oxidative stress in the inflammatory and vascular response within the pathogenesis of psoriasis and associated various cardiovascular and metabolic diseases.<\/jats:p>","DOI":"10.1093\/skinhd\/vzaf007","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:15:58Z","timestamp":1765458958000},"page":"1-11","source":"Crossref","is-referenced-by-count":1,"title":["Hypoxia and oxidative stress related to inflammation and\u00a0vascular aspects of the pathogenesis of psoriasis"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-4460","authenticated-orcid":false,"given":"Sabina C A","family":"Hanssen","sequence":"first","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M B","family":"Seyger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet E J","family":"van Erp","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina J M","family":"van der Vleuten","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C M","family":"van de Kerkhof","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026020400220418800_vzaf007-B1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"2026020400220418800_vzaf007-B2","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3389\/fimmu.2020.01984","article-title":"The role of nociceptive neurons in the pathogenesis of psoriasis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"2026020400220418800_vzaf007-B3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.seizure.2018.11.012","article-title":"Seizures as a clinical manifestation in somatic autoimmune disorders","volume":"64","author":"Amanat","year":"2019","journal-title":"Seizure"},{"key":"2026020400220418800_vzaf007-B4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00018-022-04299-x","article-title":"Cutaneous nerve fibers participate in the progression of psoriasis by linking epidermal keratinocytes and immunocytes","volume":"79","author":"Chen","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"2026020400220418800_vzaf007-B5","first-page":"36","article-title":"Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation","volume":"9","author":"Ferreira","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026020400220418800_vzaf007-B6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"2026020400220418800_vzaf007-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026020400220418800_vzaf007-B8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"2026020400220418800_vzaf007-B9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.mcna.2015.08.001","article-title":"Psoriasis and cardiovascular disease","volume":"99","author":"Shahwan","year":"2015","journal-title":"Med Clin North Am"},{"key":"2026020400220418800_vzaf007-B10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"2026020400220418800_vzaf007-B11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220418800_vzaf007-B12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaci.2019.10.015","article-title":"Epigenetic factors involved in the pathophysiology of inflammatory skin diseases","volume":"145","author":"Mobus","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026020400220418800_vzaf007-B13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in hypoxia-inducible factor biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metab"},{"key":"2026020400220418800_vzaf007-B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","article-title":"Hypoxia, oxidative stress and inflammation","volume":"125","author":"McGarry","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"Suppl 2","key":"2026020400220418800_vzaf007-B15","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2026020400220418800_vzaf007-B16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-4632.2009.04287.x","article-title":"Cutaneous vascular patterns in psoriasis","volume":"49","author":"Micali","year":"2010","journal-title":"Int J Dermatol"},{"key":"2026020400220418800_vzaf007-B17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00560390","article-title":"Structural aspects of initial psoriatic lesions","volume":"251","author":"Braun-Falco","year":"1974","journal-title":"Arch Dermatol Forsch"},{"key":"2026020400220418800_vzaf007-B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1087-0024.2000.00010.x","article-title":"The cutaneous microcirculation","volume":"5","author":"Braverman","year":"2000","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026020400220418800_vzaf007-B19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1749-6632.1964.tb52565.x","article-title":"Microcirculatory impairment as a factor in inflammatory tissue damage","volume":"116","author":"Kulka","year":"1964","journal-title":"Ann N Y Acad Sci"},{"key":"2026020400220418800_vzaf007-B20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/09546634.2013.777382","article-title":"Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin","volume":"25","author":"Hendriks","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"2026020400220418800_vzaf007-B21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/2475530321995513","article-title":"Vasculature in the margin of the psoriatic lesion","volume":"6","author":"Hanssen","year":"2021","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"2026020400220418800_vzaf007-B22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","article-title":"Upregulation of hypoxia-inducible factors in normal and psoriatic skin","volume":"127","author":"Rosenberger","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2026020400220418800_vzaf007-B24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1600-0560.2009.01264.x","article-title":"Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides","volume":"36","author":"Ioannou","year":"2009","journal-title":"J Cutan Pathol"},{"key":"2026020400220418800_vzaf007-B25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/15321819.2018.1472605","article-title":"Immunohistochemical expression HIF1alpha in chronic plaque psoriasis, an association with angiogenesis and proliferation","volume":"39","author":"Abdou","year":"2018","journal-title":"J Immunoassay Immunochem"},{"key":"2026020400220418800_vzaf007-B26","doi-asserted-by":"crossref","first-page":"e0175459","DOI":"10.1371\/journal.pone.0175459","article-title":"MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1alpha and VEGFA: implications for psoriasis treatment","volume":"12","author":"Li","year":"2017","journal-title":"PLOS ONE"},{"key":"2026020400220418800_vzaf007-B27","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/ijms20246140","article-title":"Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes","volume":"20","author":"Tirpe","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026020400220418800_vzaf007-B28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/jid.2011.141","article-title":"HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders","volume":"131","author":"Rezvani","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fped.2015.00033","article-title":"Hypoxia-inducible factor as an angiogenic master switch","volume":"3","author":"Hashimoto","year":"2015","journal-title":"Front Pediatr"},{"key":"2026020400220418800_vzaf007-B30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","article-title":"Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?","volume":"10","author":"Marrelli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2026020400220418800_vzaf007-B31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"2026020400220418800_vzaf007-B32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dnp.2008.21.2.1188196","article-title":"Angiogenesis: the new potential target for the therapy of psoriasis?","volume":"21","author":"Heidenreich","year":"2008","journal-title":"Drug News Perspect"},{"key":"2026020400220418800_vzaf007-B33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"key":"2026020400220418800_vzaf007-B34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biomedicines6020056","article-title":"Hypoxia, metabolism and immune cell function","volume":"6","author":"Krzywinska","year":"2018","journal-title":"Biomedicines"},{"key":"2026020400220418800_vzaf007-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfn032","article-title":"Why does ARNT2 behave differently from ARNT?","volume":"103","author":"Hankinson","year":"2008","journal-title":"Toxicol Sci"},{"key":"2026020400220418800_vzaf007-B36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am J Pathol"},{"key":"2026020400220418800_vzaf007-B37","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3892\/mmr.2015.3689","article-title":"Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function (review)","volume":"12","author":"Yang","year":"2015","journal-title":"Mol Med Rep"},{"key":"2026020400220418800_vzaf007-B38","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/cells10092313","article-title":"The endothelial landscape and its role in Von Hippel-Lindau disease","volume":"10","author":"de Rojas","year":"2021","journal-title":"Cells"},{"key":"2026020400220418800_vzaf007-B39","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1046\/j.0022-202X.2003.22140.x","article-title":"Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis","volume":"122","author":"Detmar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5\u2032 enhancer","volume":"77","author":"Liu","year":"1995","journal-title":"Circ Res"},{"key":"2026020400220418800_vzaf007-B41","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J Biol Chem"},{"key":"2026020400220418800_vzaf007-B42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000481204","article-title":"Response of the endothelium to the epicutaneous application of leukotriene B4","volume":"30","author":"Hanssen","year":"2017","journal-title":"Skin Pharmacol Physiol"},{"key":"2026020400220418800_vzaf007-B43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/srt.12693","article-title":"The dynamics of endothelial changes in vivo following standardized skin injury","volume":"25","author":"Hanssen","year":"2019","journal-title":"Skin Res Technol"},{"key":"2026020400220418800_vzaf007-B44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2006.02962.x","article-title":"Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis","volume":"46","author":"Tovar-Castillo","year":"2007","journal-title":"Int J Dermatol"},{"key":"2026020400220418800_vzaf007-B45","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.3390\/ijms23095226","article-title":"The protective role of pVHL in imiquimod-induced psoriasis-like skin inflammation","volume":"23","author":"Martinez-Torres","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026020400220418800_vzaf007-B46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9440(10)64062-X","article-title":"Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor\/vascular endothelial growth factor-164 gene delivery","volume":"158","author":"Sundberg","year":"2001","journal-title":"Am J Pathol"},{"key":"2026020400220418800_vzaf007-B47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"key":"2026020400220418800_vzaf007-B48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.12.013","article-title":"VEGF-A promotes IL-17A-producing gammadelta T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells","volume":"74","author":"Suzuki","year":"2014","journal-title":"J Dermatol Sci"},{"key":"2026020400220418800_vzaf007-B49","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1073\/pnas.0907550106","article-title":"Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis","volume":"106","author":"Schonthaler","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020400220418800_vzaf007-B50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2003-08-2964","article-title":"Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia","volume":"104","author":"Kunstfeld","year":"2004","journal-title":"Blood"},{"key":"2026020400220418800_vzaf007-B51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10715762.2019.1698738","article-title":"Association between genetic polymorphisms of glutathione S-transferase M1\/T1 and psoriasis in a population from the area of the strict of Messina (southern Italy)","volume":"54","author":"Guarneri","year":"2020","journal-title":"Free Radic Res"},{"key":"2026020400220418800_vzaf007-B52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijdvl.IJDVL_1128_16","article-title":"Polymorphism of glutathione S-transferase M1 and T1 genes and susceptibility to psoriasis disease: a study from North India","volume":"84","author":"Srivastava","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026020400220418800_vzaf007-B53","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","article-title":"Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis","volume":"167","author":"Asefi","year":"2012","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B54","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jid.2022.01.014","article-title":"From empirical to pathogenesis-based treatments for psoriasis","volume":"142","author":"van de Kerkhof","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B55","doi-asserted-by":"crossref","DOI":"10.1002\/9780470987421","volume-title":"Textbook of Psoriasis","author":"van de Kerkhof","year":"2003","edition":"2nd edn"},{"key":"2026020400220418800_vzaf007-B56","doi-asserted-by":"crossref","first-page":"113952","DOI":"10.1016\/j.bcp.2020.113952","article-title":"Procyanidin B2 gallate regulates TNF-alpha production from T cells through inhibiting glycolytic activity via mTOR-HIF-1 pathway","volume":"177","author":"Endo","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2026020400220418800_vzaf007-B57","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","volume":"26","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp Dermatol"},{"key":"2026020400220418800_vzaf007-B58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00403-016-1624-0","article-title":"A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress","volume":"308","author":"Yazici","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"2026020400220418800_vzaf007-B59","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/ijms18122526","article-title":"The genetic basis of psoriasis","volume":"18","author":"Capon","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026020400220418800_vzaf007-B60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study","volume":"125","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjd.21718","article-title":"Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study","volume":"187","author":"Wei","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/08958370701401418","article-title":"Oxidative stress in smokers and non-smokers","volume":"19","author":"Isik","year":"2007","journal-title":"Inhal Toxicol"},{"key":"2026020400220418800_vzaf007-B63","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026020400220418800_vzaf007-B64","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/cells11233843","article-title":"The role of oxidative stress in atherosclerosis","volume":"11","author":"Batty","year":"2022","journal-title":"Cells"},{"key":"2026020400220418800_vzaf007-B65","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"2026020400220418800_vzaf007-B66","doi-asserted-by":"crossref","first-page":"1185317","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol"},{"key":"2026020400220418800_vzaf007-B67","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.2174\/092986710793348581","article-title":"Oxidative stress in diabetic nephropathy","volume":"17","author":"Kashihara","year":"2010","journal-title":"Curr Med Chem"},{"key":"2026020400220418800_vzaf007-B68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative stress in atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"2026020400220418800_vzaf007-B69","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/10715762.2018.1500696","article-title":"Oxidative stress and atrial fibrillation: an update","volume":"52","author":"Korantzopoulos","year":"2018","journal-title":"Free Radic Res"},{"key":"2026020400220418800_vzaf007-B70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.repc.2020.12.007","article-title":"Oxidative stress and atrial fibrillation\u00a0- association or causation?","volume":"40","author":"Moscoso Costa","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"2026020400220418800_vzaf007-B71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2026020400220418800_vzaf007-B72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of HIF on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2026020400220418800_vzaf007-B73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/febs.13578","article-title":"NF-\u03baB and HIF crosstalk in immune responses","volume":"283","author":"D\u2019Ignazio","year":"2016","journal-title":"FEBS J"},{"key":"2026020400220418800_vzaf007-B74","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood-2007-10-115758","article-title":"HIF-1alpha regulates epithelial inflammation by cell autonomous NF\u03baB activation and paracrine stromal remodeling","volume":"111","author":"Scortegagna","year":"2008","journal-title":"Blood"},{"key":"2026020400220418800_vzaf007-B75","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","article-title":"The inflammatory response in mild and in severe psoriasis","volume":"150","author":"Rocha-Pereira","year":"2004","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B76","first-page":"105","article-title":"Hypoxia-inducible factors as essential regulators of inflammation","volume":"345","author":"Imtiyaz","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"2026020400220418800_vzaf007-B77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mam.2015.12.004","article-title":"The role of HIF in immunity and inflammation","volume":"47\u201348","author":"Cummins","year":"2016","journal-title":"Mol Aspects Med"},{"key":"2026020400220418800_vzaf007-B78","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"2026020400220418800_vzaf007-B79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell Metab"},{"key":"2026020400220418800_vzaf007-B80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2018.10.022","article-title":"Interleukin-6 (IL-6) triggers the malignancy of hemangioma cells via activation of HIF-1alpha\/VEGFA signals","volume":"841","author":"Fu","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"2026020400220418800_vzaf007-B81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2013.02.029","article-title":"High serum levels of HIF-1alpha in psoriatic patients correlate with an over-\u00adexpression of IL-6","volume":"62","author":"Vasilopoulos","year":"2013","journal-title":"Cytokine"},{"key":"2026020400220418800_vzaf007-B82","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.4049\/jimmunol.0901856","article-title":"Apurinic\/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses","volume":"183","author":"Lee","year":"2009","journal-title":"J Immunol"},{"key":"2026020400220418800_vzaf007-B83","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"2026020400220418800_vzaf007-B84","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12690","article-title":"Hypoxia-inhibited DUSP2 expression promotes IL-6\/STAT3 signaling in endometriosis","volume":"78","author":"Hsiao","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"2026020400220418800_vzaf007-B85","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.celrep.2018.12.012","article-title":"Regulatory T cells restrain pathogenic T helper cells during skin inflammation","volume":"25","author":"Hartwig","year":"2018","journal-title":"Cell Rep"},{"key":"2026020400220418800_vzaf007-B86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","article-title":"Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis","volume":"63","author":"Armstrong","year":"2011","journal-title":"J Dermatol Sci"},{"key":"2026020400220418800_vzaf007-B87","doi-asserted-by":"crossref","first-page":"e12946","DOI":"10.1111\/sji.12946","article-title":"The TNF\/IL-23\/IL-17 axis-head-to-head trials comparing different biologics in psoriasis treatment","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand J Immunol"},{"key":"2026020400220418800_vzaf007-B88","doi-asserted-by":"crossref","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"2026020400220418800_vzaf007-B89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B90","doi-asserted-by":"crossref","first-page":"e44519","DOI":"10.7554\/eLife.44519","article-title":"HIF-1alpha regulates IL-1beta and IL-17 in sarcoidosis","volume":"8","author":"Talreja","year":"2019","journal-title":"Elife"},{"key":"2026020400220418800_vzaf007-B91","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s10753-018-0815-6","article-title":"RNAi silencing of HIF-1alpha ameliorates lupus development in MRL\/lpr mice","volume":"41","author":"Zhao","year":"2018","journal-title":"Inflammation"},{"key":"2026020400220418800_vzaf007-B92","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"2026020400220418800_vzaf007-B93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdermsci.2016.06.002","article-title":"Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients","volume":"83","author":"Barygina","year":"2016","journal-title":"J Dermatol Sci"},{"key":"2026020400220418800_vzaf007-B94","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and\u00a0heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020400220418800_vzaf007-B95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2013.04.019","article-title":"Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase","volume":"62","author":"Youn","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"2026020400220418800_vzaf007-B96","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/ijmr.IJMR_717_16","article-title":"Dyslipidaemia & oxidative stress in patients of psoriasis: emerging cardiovascular risk factors","volume":"146","author":"Asha","year":"2017","journal-title":"Indian J Med Res"},{"key":"2026020400220418800_vzaf007-B97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol"},{"key":"2026020400220418800_vzaf007-B98","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ Res"},{"key":"2026020400220418800_vzaf007-B99","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertens Res"},{"key":"2026020400220418800_vzaf007-B100","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"Schulz","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"2026020400220418800_vzaf007-B101","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"Forstermann","year":"2017","journal-title":"Circ Res"},{"key":"2026020400220418800_vzaf007-B102","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol Cell"},{"key":"2026020400220418800_vzaf007-B103","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2026020400220418800_vzaf007-B104","first-page":"60","article-title":"Oxidative stress and antioxidants in atherosclerosis development and treatment","volume":"9","author":"Poznyak","year":"2020","journal-title":"Biology (Basel)"},{"key":"2026020400220418800_vzaf007-B105","doi-asserted-by":"crossref","first-page":"130315","DOI":"10.1155\/2015\/130315","article-title":"The role of oxidative stress and autophagy in atherosclerosis","volume":"2015","author":"Perrotta","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"2026020400220418800_vzaf007-B106","doi-asserted-by":"crossref","first-page":"1094188","DOI":"10.3389\/fcvm.2023.1094188","article-title":"Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis","volume":"10","author":"Poznyak","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026020400220418800_vzaf007-B107","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"2026020400220418800_vzaf007-B108","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.117.030484","article-title":"Inflammation and atherosclerosis: the end of a controversy","volume":"136","author":"Hansson","year":"2017","journal-title":"Circulation"},{"key":"2026020400220418800_vzaf007-B109","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/nu11092090","article-title":"Oxidative stress in cardiovascular diseases: still a therapeutic target?","volume":"11","author":"Senoner","year":"2019","journal-title":"Nutrients"},{"key":"2026020400220418800_vzaf007-B110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol Clin"},{"key":"2026020400220418800_vzaf007-B111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B112","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.56.8209","article-title":"Cardiovascular and metabolic diseases comorbid with psoriasis: beyond the skin","volume":"56","author":"Furue","year":"2017","journal-title":"Intern Med"},{"key":"2026020400220418800_vzaf007-B113","doi-asserted-by":"crossref","first-page":"864185","DOI":"10.3389\/fmed.2022.864185","article-title":"Endothelial dysfunction in psoriasis: an updated review","volume":"9","author":"Anyfanti","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2026020400220418800_vzaf007-B114","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026020400220418800_vzaf007-B115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"2026020400220418800_vzaf007-B116","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1590\/abd1806-4841.20165080","article-title":"Psoriasis comorbidities: complications and benefits of immunobiological treatment","volume":"91","author":"Carvalho","year":"2016","journal-title":"An Bras Dermatol"},{"key":"2026020400220418800_vzaf007-B117","first-page":"113","article-title":"Comorbid psoriasis and metabolic syndrome: clinical implications and optimal management","volume":"12","author":"De Brandt","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"2026020400220418800_vzaf007-B118","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00431-020-03924-w","article-title":"Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis","volume":"180","author":"Caroppo","year":"2021","journal-title":"Eur J Pediatr"},{"key":"2026020400220418800_vzaf007-B119","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.medcli.2016.12.011","article-title":"Mortality in patients with psoriasis. A retrospective cohort study","volume":"148","author":"Masson","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"2026020400220418800_vzaf007-B120","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jdv.14286","article-title":"Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate-to-severe psoriasis in five European countries","volume":"31","author":"Augustin","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B121","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","article-title":"Psoriasis and mortality in the United States: data from the National Health and Nutrition Examination Survey","volume":"85","author":"Semenov","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220418800_vzaf007-B122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-022-00832-9","article-title":"Economic burden of comorbidities in patients with psoriasis in the USA","volume":"13","author":"Wu","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026020400220418800_vzaf007-B123","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12913-017-2278-0","article-title":"Economic burden of \u00adcomorbidities in psoriasis patients in the United States: results from a retrospective U.S. database","volume":"17","author":"Feldman","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2026020400220418800_vzaf007-B124","first-page":"89","article-title":"Economic burden of generalized pustular psoriasis in Sweden: a population-based register study","volume":"12","author":"Lofvendahl","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"2026020400220418800_vzaf007-B125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026020400220418800_vzaf007-B126","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1111\/ijd.12267","article-title":"Cardiovascular aspects of psoriasis: an updated review","volume":"53","author":"Ahlehoff","year":"2014","journal-title":"Int J Dermatol"},{"key":"2026020400220418800_vzaf007-B127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/joim.12272","article-title":"Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study","volume":"277","author":"Ahlehoff","year":"2015","journal-title":"J Intern Med"},{"key":"2026020400220418800_vzaf007-B128","first-page":"1450","article-title":"Patients with psoriasis have an increased risk of cardiovascular diseases","volume":"174","author":"Ahlehoff","year":"2012","journal-title":"Ugeskr Laeger"},{"key":"2026020400220418800_vzaf007-B129","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"key":"2026020400220418800_vzaf007-B130","doi-asserted-by":"crossref","first-page":"e18125","DOI":"10.1371\/journal.pone.0018125","article-title":"Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study","volume":"6","author":"Ahlehoff","year":"2011","journal-title":"PLOS ONE"},{"key":"2026020400220418800_vzaf007-B131","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/jdv.13152","article-title":"Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study","volume":"30","author":"Ahlehoff","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B132","doi-asserted-by":"crossref","first-page":"e36342","DOI":"10.1371\/journal.pone.0036342","article-title":"Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries","volume":"7","author":"Ahlehoff","year":"2012","journal-title":"PLOS ONE"},{"key":"2026020400220418800_vzaf007-B133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-020-02101-1","article-title":"Psoriasis severity matters when dealing with all-cause mortality in psoriasis patients: a record linkage analysis in northern Italy","volume":"313","author":"Pezzolo","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"2026020400220418800_vzaf007-B134","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0003319716652284","article-title":"Assessment of arterial stiffness in Korean patients with psoriasis by cardio-ankle vascular index","volume":"68","author":"Choi","year":"2017","journal-title":"Angiology"},{"key":"2026020400220418800_vzaf007-B135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000182256","article-title":"Chronic plaque psoriasis is associated with increased arterial stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology"},{"key":"2026020400220418800_vzaf007-B136","doi-asserted-by":"crossref","first-page":"8061901","DOI":"10.1155\/2019\/8061901","article-title":"The oxidative stress-induced miR-200c is upregulated in psoriasis and correlates with disease severity and determinants of cardiovascular risk","volume":"2019","author":"Magenta","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"2026020400220418800_vzaf007-B137","first-page":"434","article-title":"Mild to moderate psoriasis is associated with oxidative stress, subclinical atherosclerosis, and endothelial dysfunction","volume":"128","author":"Haberka","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"2026020400220418800_vzaf007-B138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"key":"2026020400220418800_vzaf007-B139","doi-asserted-by":"crossref","first-page":"14","DOI":"10.23736\/S0392-0488.17.05621-8","article-title":"Effects of TNF\u03b1 inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study","volume":"155","author":"Merlo","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5001\/omj.2016.78","article-title":"Is the ratio of antibodies against oxidized LDL to oxidized LDL an indicator of cardiovascular risk in psoriasis?","volume":"31","author":"Sunitha","year":"2016","journal-title":"Oman Med J"},{"key":"2026020400220418800_vzaf007-B141","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10238-014-0323-4","article-title":"Metabolic syndrome and chronic arthritis: effects of anti-TNF-\u03b1 therapy","volume":"15","author":"Maruotti","year":"2015","journal-title":"Clin Exp Med"},{"key":"2026020400220418800_vzaf007-B142","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1111\/ijd.13196","article-title":"Effect of anti\u00adpsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasis","volume":"55","author":"Rajappa","year":"2016","journal-title":"Int J Dermatol"},{"key":"2026020400220418800_vzaf007-B143","doi-asserted-by":"crossref","first-page":"e12566","DOI":"10.1111\/dth.12566","article-title":"Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents","volume":"31","author":"Al Mutairi","year":"2018","journal-title":"Dermatol Ther"},{"key":"2026020400220418800_vzaf007-B144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00403-019-01896-y","article-title":"Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case-control study","volume":"311","author":"Wadhwa","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"2026020400220418800_vzaf007-B145","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/JIR.S276982","article-title":"Insights into the role of inflammation in the management of atherosclerosis","volume":"16","author":"Rocha","year":"2023","journal-title":"J Inflamm Res"},{"key":"2026020400220418800_vzaf007-B146","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.bbalip.2014.09.008","article-title":"Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein","volume":"1841","author":"He","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2026020400220418800_vzaf007-B147","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpba.2018.03.068","article-title":"Proteomic plasma profile of psoriatic patients","volume":"155","author":"Gegotek","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"2026020400220418800_vzaf007-B148","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0009-8981(02)00373-X","article-title":"Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis","volume":"328","author":"Vanizor Kural","year":"2003","journal-title":"Clin Chim Acta"},{"key":"2026020400220418800_vzaf007-B149","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2133.2011.10539.x","article-title":"Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1","volume":"166","author":"Ferretti","year":"2012","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cbf.3011","article-title":"Antioxidant status in patients with psoriasis","volume":"32","author":"Nemati","year":"2014","journal-title":"Cell Biochem Funct"},{"key":"2026020400220418800_vzaf007-B151","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1468-3083.2011.03982.x","article-title":"The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis","volume":"25","author":"Kaur","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B152","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.118.313608","article-title":"Association between oxidation-modified lipoproteins and coronary plaque in psoriasis","volume":"123","author":"Sorokin","year":"2018","journal-title":"Circ Res"},{"key":"2026020400220418800_vzaf007-B153","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3390\/ijms20174249","article-title":"Altered lipid metabolism in blood mononuclear cells of psoriatic patients indicates differential changes in psoriasis vulgaris and psoriatic arthritis","volume":"20","author":"Wojcik","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026020400220418800_vzaf007-B154","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jdv.12595","article-title":"The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study","volume":"29","author":"Miller","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2340\/00015555-0510","article-title":"Psoriasis and dyslipidaemia: a population-based study","volume":"88","author":"Dreiher","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"2026020400220418800_vzaf007-B156","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bjd.12101","article-title":"The association between psoriasis and dyslipidaemia: a systematic review","volume":"168","author":"Ma","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B157","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bjd.12490","article-title":"Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis","volume":"169","author":"Miller","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B158","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2133.2004.05801.x","article-title":"Erythrocyte damage in mild and severe psoriasis","volume":"150","author":"Rocha-Pereira","year":"2004","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B159","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1468-3083.2007.02260.x","article-title":"The lipid profile in psoriasis: a controlled study","volume":"21","author":"Akhyani","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026020400220418800_vzaf007-B160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026020400220418800_vzaf007-B161","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamadermatol.2013.9957","article-title":"Hypertension, antihypertensive medication use, and risk of psoriasis","volume":"150","author":"Wu","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2026020400220418800_vzaf007-B162","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jid.2018.03.1522","article-title":"High-fat diet exacerbates early psoriatic skin inflammation independent of obesity: saturated fatty acids as key players","volume":"138","author":"Herbert","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2026020400220418800_vzaf007-B163","doi-asserted-by":"crossref","first-page":"e0202854","DOI":"10.1371\/journal.pone.0202854","article-title":"Hypertension and risk of psoriasis incidence: an 11-year nationwide population-based cohort study","volume":"13","author":"Kim","year":"2018","journal-title":"PLOS ONE"},{"key":"2026020400220418800_vzaf007-B164","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","article-title":"Psoriasis: obesity and fatty acids","volume":"10","author":"Kunz","year":"2019","journal-title":"Front Immunol"},{"key":"2026020400220418800_vzaf007-B165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12895-016-0049-y","article-title":"Randomized placebo control study of insulin sensitizers (metformin and pioglitazone) in psoriasis patients with metabolic syndrome (topical treatment cohort)","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Dermatol"},{"key":"2026020400220418800_vzaf007-B166","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4103\/ijem.IJEM_46_17","article-title":"Randomized placebo control study of metformin in psoriasis patients with metabolic syndrome (systemic treatment cohort)","volume":"21","author":"Singh","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"2026020400220418800_vzaf007-B167","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/jpm11040251","article-title":"Is metformin a possible beneficial treatment for psoriasis? A scoping review","volume":"11","author":"Stanescu","year":"2021","journal-title":"J Pers Med"},{"key":"2026020400220418800_vzaf007-B168","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaad.2007.11.023","article-title":"Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study","volume":"58","author":"Brauchli","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220418800_vzaf007-B169","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2014.08.042","article-title":"Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case-control study in Taiwan","volume":"72","author":"Wu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220418800_vzaf007-B170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/ebmed-2011-100388","article-title":"Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis","volume":"17","author":"Malhotra","year":"2012","journal-title":"Evid Based Med"},{"key":"2026020400220418800_vzaf007-B171","doi-asserted-by":"crossref","first-page":"e12675","DOI":"10.1111\/dth.12675","article-title":"Secukinumab reduces plasma oxidative stress in psoriasis: a case-based experience","volume":"31","author":"Becatti","year":"2018","journal-title":"Dermatol Ther"},{"key":"2026020400220418800_vzaf007-B172","first-page":"704","article-title":"Assessment of some oxidative stress parameters in methotrexate treated psoriasis patients","volume":"62","author":"Boda","year":"2014","journal-title":"Farmacia"},{"key":"2026020400220418800_vzaf007-B173","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/bjd.12144","article-title":"Oxidative stress and psoriasis: the effect of antitumour necrosis factor-\u03b1 inhibitor treatment","volume":"168","author":"Bacchetti","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026020400220418800_vzaf007-B174","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","article-title":"Oxidative stress in the pathogenesis of psoriasis","volume":"47","author":"Zhou","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"2026020400220418800_vzaf007-B175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/antiox11020282","article-title":"The involvement of oxidative stress in psoriasis: a systematic review","volume":"11","author":"Dobrica","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2026020400220418800_vzaf007-B176","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1002\/hsr2.389","article-title":"The association of oxidative stress biomarkers with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"4","author":"Banik","year":"2021","journal-title":"Health Sci Rep"},{"key":"2026020400220418800_vzaf007-B177","first-page":"659","article-title":"Oxidative stress: a unifying paradigm in hypertension","volume":"36","author":"Touyz","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026020400220418800_vzaf007-B178","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10715762.2021.1931166","article-title":"The association of glutathione S-transferase T1 and M1 deletions with myocardial infarction","volume":"55","author":"Zivkovic","year":"2021","journal-title":"Free Radic Res"},{"key":"2026020400220418800_vzaf007-B179","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12881-020-0990-9","article-title":"Glutathione S-transferase M1 and T1 genes deletion polymorphisms and risk of developing essential hypertension: a case-control study in Burkina Faso population (West Africa)","volume":"21","author":"Sombie","year":"2020","journal-title":"BMC Med Genet"},{"key":"2026020400220418800_vzaf007-B180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13104-021-05658-w","article-title":"Glutathione S-transferase M1 and T1 genes deletion polymorphisms and blood pressure control among treated essential hypertensive patients in Burkina Faso","volume":"14","author":"Sombie","year":"2021","journal-title":"BMC Res Notes"},{"key":"2026020400220418800_vzaf007-B181","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2217\/14622416.8.10.1307","article-title":"Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese","volume":"8","author":"Hori","year":"2007","journal-title":"Pharmacogenomics"},{"key":"2026020400220418800_vzaf007-B182","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000442165","article-title":"Glutathione S-transferase M1 and T1 gene polymorphisms in patients with chronic plaque-type psoriasis: a case-control study","volume":"25","author":"Solak","year":"2016","journal-title":"Med Princ Pract"},{"key":"2026020400220418800_vzaf007-B183","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/nutrit\/nuv042","article-title":"Glutathionyl systems\u00a0and metabolic dysfunction in obesity","volume":"73","author":"Picklo","year":"2015","journal-title":"Nutr Rev"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/1\/1\/66004162\/vzaf007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/1\/1\/66004162\/vzaf007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:22:31Z","timestamp":1770182551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/1\/1\/8383475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,18]]},"published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf007","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,18]]}}}